SEARCH

SEARCH BY CITATION

References

  • 1
    Hansbro NG, Horvat JC, Wark PA, Hansbro PM. Understanding the mechanisms of viral induced asthma: new therapeutic directions. Pharmacol Ther 2008; 117:313353.
  • 2
    Heymann PW, Carper HT, Murphy DD et al. Viral infections in relation to age, atopy, and season of admission among children hospitalized for wheezing. J Allergy Clin Immunol 2004; 114:239247.
  • 3
    Chung KF. Cytokines in chronic obstructive pulmonary disease. Eur Respir J 2001; 18:50s59s.
  • 4
    Masoli M, Fabian D, Holt S, Beasley R. Global Initiative for Asthma (GINA) Program. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004; 59:469478.
  • 5
    Falsey AR, Formica MA, Walsh EE. Diagnostic of respiratory syncytial virus infection: comparison of reverse transcription-PCR to viral culture and serology in adults with respiratory illness. J Clin Microbiol 2002; 40:817820.
  • 6
    Arnold R, Konig W. Respiratory syncytial virus infection of human lung endothelial cells enhances selectively intercellular adhesion molecule-1 expression. J Immunol 2005; 174:73597367.
  • 7
    Costa EL, Schettino IA, Schettino GP. The lung in sepsis: guilty or innocent? Endocr Metab Immune Disord Drug Targets 2006; 6:213216.
  • 8
    Tirado R, Ortega A, Sarmiento RE, Gómez B. Interleukin-8 mRNA synthesis and protein secretion are continuously up-regulated by respiratory syncytial virus persistently infected cells. Cell Immunol 2005; 233:6171.
  • 9
    Rose CE Jr, Sung SS, Fu SM. Significant involvement of CCL2 (MCP-1) in inflammatory disorders of the lung. Microcirculation 2003; 10:273288.
  • 10
    Conti P, DiGioacchino M. MCP-1 and RANTES are mediators of acute and chronic inflammation. Allergy Asthma Proc 2001; 22:133137.
  • 11
    Morrison PT, Sharland M, Thomas LH et al. Chemokine-receptor upregulation and disease severity in respiratory syncytial virus infection. Clin Immunol 2008; 128:8593.
  • 12
    Hackett TL, Singhera GK, Shaheen F et al. Intrinsic phenotypic differences of asthmatic epithelium and its inflammatory responses to RSV and air pollution. Am J Respir Cell Mol Biol 2011; 45:10901100.
  • 13
    Kallal LE, Lukacs NW. The role of chemokines in virus-associated asthma exacerbations. Curr Allergy Asthma Rep 2008; 8:443450.
  • 14
    Zeng R, Li C, Li N, Wei L, Cui Y. The role of cytokines and chemokines in severe respiratory syncytial virus infection and subsequent asthma. Cytokine 2011; 53:17.
  • 15
    Crosby LM. Waters CM: epithelial repair mechanisms in the lung. Am J Physiol Lung Cell Mol Physiol 2010; 298:L715L731.
  • 16
    Morissette MC, Parent J, Milot J. Alveolar epithelial and endothelial cell apoptosis in emphysema: what we know and what we need to know. Int J Chron Obstruct Pulmon Dis 2009; 4:1931.
  • 17
    Lim S, Roche N, Oliver BG, Mattos W, Barnes PJ, Chung KF. Balance of matrix metalloprotease-9 and tissue inhibitor of metalloprotease-1 from alveolar macrophages in cigarette smokers: regulation by interleukin-10. Am J Respir Crit Care Med 2000; 162:13551360.
  • 18
    Riise GC, Larsson S, Lofdahl CG, Andersson BA. Circulating cell adhesion molecules in bronchial lavage and serum in COPD patients with chronic bronchitis. Eur Respir J 1994; 7:16731677.
  • 19
    Bem RA, Bos AP, Wosten-van Asperen RM et al. Potential role of soluble TRAIL in epithelial injury in children with severe RSV infection. Am J Respir Cell Mol Biol 2010; 42:697705.
  • 20
    Pryhuber GS, Bachurski C, Hirsch R, Bacon A, Whitsett JA. Tumor necrosis factor-alpha decreases surfactant protein B mRNA in murine lung. Am J Physiol 1996; 270:L714721.
  • 21
    Henderson C, Goldbach-Mansky R. Monogenic. Autoinflammatory diseases: new insights into clinical aspects and pathogenesis. Curr Opin Rheumatol 2010; 22:567578.
  • 22
    Hal M. Inflammasome and IL-1β-mediated disorders. Curr Allergy Asthma Rep 2010; 10:229235.
  • 23
    Makó V, Czúcz J, Weiszhár Z et al. Proinflammatory activation pattern of human umbilical vein endothelial cells induced by IL-1β, TNF-α, and LPS. Cytometry A 2010; 77:962970.
  • 24
    Lampinen M, Carlson M, Hakansson LD, Venge P. Cytokine-regulated accumulation of eosinophils in inflammatory disease. Allergy 2004; 59:793805.
  • 25
    Levine SJ, Wenzel SE. The role of Th2 immune pathway modulation in the treatment of severe asthma and its phenotypes: are we getting closer? Ann Intern Med 2010; 152:232237.
  • 26
    Luzina IG, Keegan AD, Heller NM, Rook GA, Shea-Donohue T, Atamas SP. Regulation of inflammation by interleukin-4: a review of “alternatives”. J Leukoc Biol 2012; 92:753764.
  • 27
    Koyasu S, Moro K. Role of innate lymphocytes in infection and inflammation. Front Immunol 2012; 3:101.
  • 28
    Leung DY. Atopic dermatitis: the skin as a window into the pathogenesis of chronic allergic diseases. J Allergy Clin Immunol 1995; 96:302318.
  • 29
    Gotera J, Giuffrida M, Mavarez A et al. Respiratory syncytial virus infection increases regulated on activation normal T cell expressed and secreted and monocyte chemotactic protein 1 levels in serum of patients with asthma and in human monocyte cultures. Ann Allergy Asthma Immunol 2012; 108:316320.
  • 30
    You D, Becnel D, Wang K, Ripple M, Daly M, Cormier SA. Exposure of neonates to respiratory syncytial virus is critical in determining subsequent airway response in adults. Respir Res 2006; 7:107117.